Hülya Yılmaz

2.3k total citations
134 papers, 1.8k citations indexed

About

Hülya Yılmaz is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hülya Yılmaz has authored 134 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 26 papers in Surgery and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hülya Yılmaz's work include Peroxisome Proliferator-Activated Receptors (15 papers), Lipoproteins and Cardiovascular Health (13 papers) and Folate and B Vitamins Research (13 papers). Hülya Yılmaz is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (15 papers), Lipoproteins and Cardiovascular Health (13 papers) and Folate and B Vitamins Research (13 papers). Hülya Yılmaz collaborates with scholars based in Türkiye, Hungary and Norway. Hülya Yılmaz's co-authors include Turgay İşbir, Bedia Ağaçhan, Oğuz Öztürk, Zeynep Karaali, Arzu Ergen, Özlem Küçükhüseyin, Atike Tekeli, Emel Akoğlu, İftihar Köksal and Makbule Aydın and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and FEBS Letters.

In The Last Decade

Hülya Yılmaz

122 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hülya Yılmaz Türkiye 24 489 344 296 269 252 134 1.8k
Raúl R. Rodrigues-Díez Spain 31 1.2k 2.5× 316 0.9× 210 0.7× 431 1.6× 101 0.4× 72 3.1k
Chiara Stranieri Italy 31 527 1.1× 485 1.4× 290 1.0× 301 1.1× 136 0.5× 53 1.9k
Anna V. Mathew United States 23 1.3k 2.6× 221 0.6× 341 1.2× 267 1.0× 96 0.4× 51 2.6k
Paweł Wołkow Poland 25 687 1.4× 376 1.1× 254 0.9× 288 1.1× 50 0.2× 106 2.0k
Josep Ribalta Spain 30 608 1.2× 513 1.5× 713 2.4× 687 2.6× 143 0.6× 118 2.4k
Zhen Yang China 24 471 1.0× 387 1.1× 294 1.0× 411 1.5× 62 0.2× 98 1.8k
Touhami Mahjoub Tunisia 29 475 1.0× 345 1.0× 322 1.1× 249 0.9× 289 1.1× 149 2.6k
Hassan Argani Iran 25 336 0.7× 117 0.3× 271 0.9× 289 1.1× 91 0.4× 113 1.8k
Masahiro Nezu Japan 13 901 1.8× 405 1.2× 319 1.1× 554 2.1× 53 0.2× 26 3.0k
Lambertus J.H. van Tits Netherlands 21 295 0.6× 180 0.5× 149 0.5× 320 1.2× 179 0.7× 50 1.7k

Countries citing papers authored by Hülya Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Hülya Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hülya Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hülya Yılmaz more than expected).

Fields of papers citing papers by Hülya Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hülya Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hülya Yılmaz. The network helps show where Hülya Yılmaz may publish in the future.

Co-authorship network of co-authors of Hülya Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Hülya Yılmaz. A scholar is included among the top collaborators of Hülya Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hülya Yılmaz. Hülya Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yılmaz, Hülya, et al.. (2025). Chromatographic analysis and pKa evaluation of active pharmaceutical ingredients in anti-metastatic breast cancer: Green vs. conventional RPLC. Journal of Pharmaceutical and Biomedical Analysis. 256. 116671–116671. 3 indexed citations
2.
3.
Öztürk, Tülin, et al.. (2023). Synergistic and Dose-Dependent Effects of Pinostrobin, Pinocembrin and Pinobanksin on Different Breast Cancer Cell Lines. Kafkas Universitesi Veteriner Fakultesi Dergisi. 1 indexed citations
4.
Yıldız, Ahmet, et al.. (2022). Next-generation sequencing of prolidase gene identifies novel and common variants associated with low prolidase in coronary artery ectasia. Molecular Biology Reports. 50(2). 1349–1365. 1 indexed citations
5.
6.
Öztürk, Oğuz, et al.. (2020). Kanser ve Metastaz: Hücre Adezyon Molekülleri ve Hücreler Arası Bağlantıların Önemi. 10(1). 38–48. 1 indexed citations
7.
Buğra, Zehra, et al.. (2019). KORONER KALP HASTALARINDA CAV1 rs3807990 VARYASYONUNUN LİPİD PROFİLİNDE DİYABETİK KOŞULLARA GÖRE FARKLI ETKİLERİ. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 83(1). 23–29.
8.
Ekmekçi, Ahmet, et al.. (2019). Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey. Molecular Biology Reports. 46(2). 1825–1833. 9 indexed citations
9.
Çoşkunpınar, Ender, et al.. (2019). Role of SNPs of CPTIA and CROT genes in the carnitine-shuttle in coronary artery disease: a case-control study. Turkish Journal of Biochemistry. 44(6). 822–830. 2 indexed citations
10.
Pençe, Sadrettin, et al.. (2019). Effects of SR-BI rs5888 and rs4238001 variations on hypertension. Turkish Journal of Biochemistry. 44(4). 549–553. 1 indexed citations
11.
Yılmaz, Gürdal, et al.. (2016). The prognostic significance of serum TGF‐β1 levels in patients with Crimean‐Congo hemorrhagic fever. Journal of Medical Virology. 89(3). 413–416. 3 indexed citations
12.
Toptaş, Bahar, et al.. (2012). Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues. DNA and Cell Biology. 32(1). 13–18. 15 indexed citations
13.
Yılmaz, Hülya, Özlem Küçükhüseyin, Özlem Kar Kurt, et al.. (2012). Investigation of Polymorphic Variants of PPARD and APOE Genes in Turkish Coronary Heart Disease Patients. DNA and Cell Biology. 31(5). 867–875. 13 indexed citations
14.
Cacına, Canan, Özlem Timirci Kahraman, Özlem Kar Kurt, et al.. (2011). MCP-1 and CCR2 Gene Variants and the Risk for Osteoporosis and Osteopenia. Genetic Testing and Molecular Biomarkers. 16(4). 229–233. 15 indexed citations
15.
Yılmaz, Hülya, Özlem Küçükhüseyin, Atike Tekeli, & Turgay İşbir. (2011). Associations of Receptor for Advanced Glycation End Products -374 T/A and Gly82 Ser and Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala Polymorphisms in Turkish Coronary Artery Disease Patients. Genetic Testing and Molecular Biomarkers. 16(2). 134–137. 17 indexed citations
16.
Ağaçhan, Bedia, Rükset Attar, Elif İşbilen, et al.. (2010). Association of Monocyte Chemotactic Protein-1 and CC Chemokine Receptor 2 Gene Variants with Preeclampsia. Journal of Interferon & Cytokine Research. 30(9). 673–676. 5 indexed citations
17.
İşbilen, Elif, Hülya Yılmaz, Arzu Ergen, et al.. (2009). Association of Paraoxonase 55 and 192 Gene Polymorphisms on Serum Homocysteine Concentrations in Preeclampsia. Folia Biologica. 55(2). 35–40. 7 indexed citations
18.
Özger, Harzem, Hülya Yılmaz, Arzu Ergen, et al.. (2008). Methylenetetrahydrofolate Reductase C677T Gene Polymorphism in Osteosarcoma and Chondrosarcoma Patients. Folia Biologica. 54(2). 53–57. 4 indexed citations
19.
Yılmaz, Hülya, et al.. (2004). Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochemistry and Function. 23(1). 23–28. 31 indexed citations
20.
Ağaçhan, Bedia, Hülya Yılmaz, Zeynep Karaali, & Turgay İşbir. (2004). Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non‐insulin dependent diabetes mellitus. Cell Biochemistry and Function. 22(3). 163–168. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raúl R. Rodrigues-Díez Breakdown of academic impact, for papers by Chiara Stranieri Breakdown of academic impact, for papers by Anna V. Mathew Breakdown of academic impact, for papers by Paweł Wołkow Breakdown of academic impact, for papers by Josep Ribalta Breakdown of academic impact, for papers by Zhen Yang Breakdown of academic impact, for papers by Touhami Mahjoub Breakdown of academic impact, for papers by Hassan Argani Breakdown of academic impact, for papers by Masahiro Nezu Breakdown of academic impact, for papers by Lambertus J.H. van Tits
Rankless by CCL
2026